Study on the effect of acupressure for reducing blood pressure

Tomooka Kiyohide0 个研究点目标入组 80 人开始时间: 2022年8月3日最近更新: 2024年4月1日

试验速览

暂无简介。

•1) Men and women aged 35 years or higher to less than 75 years old
•2) Participants who are able to participate research explanatory meeting, first and last examination
•3) Participants who are able to do acupressure by themselves at home
•3) Participants who had systolic blood pressure of 125 mmHg or higher or diastolic blood pressure of 75 mmHg or higher by measuring home blood pressure
•5) Participants who have an Internet environment that allows video calls via Zoom
•6) Participatns who are able to communicate via E-mail
•7) Participants who voluntarily provide their informed consent after receiving a full explanation of the study

•1) Those whose systolic blood pressure is 135 mmHg or higher or diastolic blood pressure is 85 mmHg or higher for all three days of home blood pressure measurements, who are not taking antihypertensive medication and who have not obtained permission from their primary care physician.
•2) Those with secondary hypertension (diabetes, chronic kidney disease, thyroid or endocrine disorders, etc.).
•3) Patients whose home blood pressure measurements over a 3-day period were all Grade III hypertension (systolic blood pressure of 160 mmHg or higher or diastolic blood pressure of 100 mmHg or higher).
•4) Patients with a history of stroke or myocardial infarction.
•5) Pregnant or planning to become pregnant during the study period.
•6) Those with metal allergies.
•*In the case of untreated hypertensive subjects whose average home blood pressure (averaged over 3 days) at the time of application is found to be 135 mmHg systolic or 85 mmHg diastolic or higher, the subject's medical history will be interviewed and a decision will be made after consultation with the physician as to whether the subject may participate in the study. If necessary, we will issue a written request for medical examination and recommend that the subject visit his/her family doctor or other health care provider.
•*For 2), those whose symptoms have been stabilized by medication and those who have obtained consent from their physicians will be allowed to participate in the study.

发起方

Tomooka Kiyohide